Twin study aims to unlock secrets of metabolic syndrome and liver disease

NCT ID NCT07181018

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study follows 1,500 twins aged 15-44 in Poland over 5 years to learn how metabolic syndrome and related liver problems develop. Researchers will look at genetics, environment, and gut bacteria. Some twins will get an educational program to encourage healthy changes, while their co-twin serves as a control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
educational intervention
What this could lead to
If successful, this could reveal key risk factors and genetic influences for metabolic syndrome and liver disease, pointing toward better prevention strategies.
What could go wrong
This is an observational study with an educational component, not a treatment trial. Results may not apply to non-twin populations, and the intervention's impact may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uniwersytecki Szpital Kliniczny

    RECRUITING

    Poznan, Wielkopolska, 60-355, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.